RHHBF - ADC Therapeutics gains after data for lymphoma therapy
2024-04-04 13:11:10 ET
More on ADC Therapeutics
- ADC Therapeutics: Real Opportunity With Real Risk In 2024 (Rating Upgrade)
- ADC Therapeutics SA (ADCT) Q4 2023 Earnings Call Transcript
- ADC Therapeutics SA 2023 Q4 - Results - Earnings Call Presentation
- Seeking Alpha’s Quant Rating on ADC Therapeutics
- Historical earnings data for ADC Therapeutics